September 27, 2022 Comments Off on New patent for Astrazeneca drug LYNPARZA Posted in: Patent Added Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent for Astrazeneca drug LYNPARZA appeared first…
September 24, 2022 Comments Off on New patent for Pharmacyclics Inc drug IMBRUVICA Posted in: Patent Added Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are forty patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared fi…